当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析 - 现金流量表

双鹭药业

(002038)

  

流通市值:48.15亿  总市值:58.05亿
流通股本:8.52亿   总股本:10.27亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金285,551,632.71234,161,730.03706,218,709.51,148,962,111.33
  收到的税费返还4,742.114,714.836,677,353.56,682,168.72
  收到其他与经营活动有关的现金247,444,421.962,667,964.47624,924,602.0311,095,125.97
  经营活动现金流入小计533,000,796.78236,834,409.331,337,820,665.031,166,739,406.02
  购买商品、接受劳务支付的现金78,479,352.85102,236,964.14106,189,885.85941,881,923.99
  支付给职工以及为职工支付的现金74,131,554.5140,053,010.36132,206,662.43102,694,043.5
  支付的各项税费23,838,048.5212,336,587.9833,278,961.8621,679,589.9
  支付其他与经营活动有关的现金128,207,00023,552,165.2808,481,885.76106,315,586.93
  经营活动现金流出小计304,655,955.88178,178,727.681,080,157,395.91,172,571,144.32
  经营活动产生的现金流量净额228,344,840.958,655,681.65257,663,269.13-5,831,738.3
二、投资活动产生的现金流量:
  收回投资收到的现金470,000,000120,000,000319,824,722.2250,000,000
  取得投资收益收到的现金29,003,983.9312,359,242.746,237,584.8924,553,591.71
  处置固定资产、无形资产和其他长期资产收回的现金净额--600-
  收到的其他与投资活动有关的现金--37,812.32-
  投资活动现金流入小计499,003,983.93132,359,242.7366,100,719.41274,553,591.71
  购建固定资产、无形资产和其他长期资产支付的现金15,271,764.486,378,662.71192,971,730.61155,025,786.75
  投资支付的现金450,000,000100,000,000293,427,030130,000,000
  支付其他与投资活动有关的现金--18,982,609.39-
  投资活动现金流出小计465,271,764.48106,378,662.71505,381,370285,025,786.75
  投资活动产生的现金流量净额33,732,219.4525,980,579.99-139,280,650.59-10,472,195.04
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-50,000,000--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-50,000,000--
  分配股利、利润或偿付利息支付的现金--17,895,318.8620,547,000
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--17,895,318.8620,547,000
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额-50,000,000-17,895,318.86-20,547,000
四、汇率变动对现金及现金等价物的影响-16.73-9.676.7311.44
五、现金及现金等价物净增加额262,077,043.62134,636,251.97100,487,306.41-36,850,921.9
  加:期初现金及现金等价物余额500,365,555.38500,365,555.38399,878,248.97399,878,248.97
  期末现金及现金等价物余额762,442,599635,001,807.35500,365,555.38363,027,327.07
补充资料:
  净利润-255,807,233.58--348,208,492.02-
  资产减值准备3,267,227.88-27,461,410.02-
  固定资产和投资性房地产折旧21,017,079.76-42,302,530.75-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧21,017,079.76-42,302,530.75-
  无形资产摊销62,338,870.12-124,481,490.29-
  长期待摊费用摊销139,470.08-278,940.16-
  处置固定资产、无形资产和其他长期资产的损失5,846.42-46,020.43-
  固定资产报废损失---754.65-
  公允价值变动损失312,539,601.67--353,806,373.8-
  投资损失-7,564,799.32--13,380,373.66-
  递延所得税-43,390,677.79-63,687,549.96-
  其中:递延所得税资产减少3,461,555.68-15,822,496.93-
    递延所得税负债增加-46,852,233.47-47,865,053.03-
  存货的减少540,259,850.2--436,264,537.82-
  经营性应收项目的减少90,170,023.14--14,764,199.16-
  经营性应付项目的增加-494,630,417.68-544,683,193.85-
  其他--621,146,864.78-
  现金的期末余额762,442,599-500,365,555.38-
  减:现金的期初余额500,365,555.38-399,878,248.97-
  现金及现金等价物的净增加额262,077,043.62-100,487,306.41-
公告日期2026-08-262026-04-292026-04-292025-10-27
审计意见(境内)标准无保留意见
TOP↑